You are researching: Embrionic Kidney (HEK)
Matching entries: 3 /3
All Groups
AUTHOR Krstić, Nenad and Jüttner, Jens and Giegerich, Lars and Mayer, Margot and Knuth, Monika and Müller, Achim and Thielemann, Christiane
Title 3D printed biosensor for continuous glucose measurement in cell cultures [Abstract]
Year 2023
Journal/Proceedings Annals of 3D Printed Medicine
A novel 3D-printed glucose sensor is presented for cell culture application. Glucose sensing was performed using a fluorescence resonance energy transfer (FRET)-based assay principle based on ConA and dextran. Both molecules are encapsulated in alginate microspheres and embedded in the UV-curable, stable hydrogel polyvinyl alcohol (PVA). The rheology of the formulation was adapted to obtain good properties for an extrusion-based printing process. The printed sensor structures were tested for their ability to detect glucose in vitro. A proportional increase in fluorescence intensity was observed in a concentration range of 0 - 2 g/L glucose. Tests with HEK cell cultures also showed good cell compatibility and excellent adhesion properties on plasma-treated Petri dishes. The printed sensors were able to detect the glucose decay associated with the metabolic activities of the fast-growing HEK cells in the cell culture medium over ten days. The proof-of-principle study shows that metabolic processes in cell cultures can be monitored with the new printed sensor using a standard fluorescence wide-field microscope.
AUTHOR Trossmann, Vanessa T. and Heltmann-Meyer, Stefanie and Amouei, Hanna and Wajant, Harald and Horch, Raymund E. and Steiner, Dominik and Scheibel, Thomas
Title Recombinant Spider Silk Bioinks for Continuous Protein Release by Encapsulated Producer Cells [Abstract]
Year 2022
Journal/Proceedings Biomacromolecules
Targeted therapies using biopharmaceuticals are of growing clinical importance in disease treatment. Currently, there are several limitations of protein-based therapeutics (biologicals), including suboptimal biodistribution, lack of stability, and systemic side effects. A promising approach to overcoming these limitations could be a therapeutic cell-loaded 3D construct consisting of a suitable matrix component that harbors producer cells continuously secreting the biological of interest. Here, the recombinant spider silk proteins eADF4(C16), eADF4(C16)-RGD, and eADF4(C16)-RGE have been processed together with HEK293 producer cells stably secreting the highly traceable reporter biological TNFR2-Fc-GpL, a fusion protein consisting of the extracellular domain of TNFR2, the Fc domain of human IgG1, and the luciferase of Gaussia princeps as a reporter domain. eADF4(C16) and eADF4(C16)-RGD hydrogels provide structural and mechanical support, promote HEK293 cell growth, and allow fusion protein production by the latter. Bioink-captured HEK293 producer cells continuously release functional TNFR2-Fc-GpL over 14 days. Thus, the combination of biocompatible, printable spider silk bioinks with drug-producing cells is promising for generating implantable 3D constructs for continuous targeted therapy.
AUTHOR Allig, Sebastian and Mayer, Margot and Thielemann, Christiane
Title Workflow for bioprinting of cell-laden bioink
Year 2018
Journal/Proceedings Lekar a Technika